ATE402255T1 - Surfactant protein d zur vorbeugung und diagnose des lungenemphysems - Google Patents
Surfactant protein d zur vorbeugung und diagnose des lungenemphysemsInfo
- Publication number
- ATE402255T1 ATE402255T1 AT99958659T AT99958659T ATE402255T1 AT E402255 T1 ATE402255 T1 AT E402255T1 AT 99958659 T AT99958659 T AT 99958659T AT 99958659 T AT99958659 T AT 99958659T AT E402255 T1 ATE402255 T1 AT E402255T1
- Authority
- AT
- Austria
- Prior art keywords
- emphysema
- diagnosis
- protein
- surfactant protein
- prevention
- Prior art date
Links
- 108010007127 Pulmonary Surfactant-Associated Protein D Proteins 0.000 title abstract 8
- 102100027845 Pulmonary surfactant-associated protein D Human genes 0.000 title abstract 7
- 206010014561 Emphysema Diseases 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 108090000909 Collectins Proteins 0.000 abstract 1
- 102000004405 Collectins Human genes 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 108090001090 Lectins Proteins 0.000 abstract 1
- 102000004856 Lectins Human genes 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 abstract 1
- 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 abstract 1
- 102100027773 Pulmonary surfactant-associated protein A2 Human genes 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 210000001132 alveolar macrophage Anatomy 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 210000001671 embryonic stem cell Anatomy 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 230000006801 homologous recombination Effects 0.000 abstract 1
- 238000002744 homologous recombination Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000002523 lectin Substances 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000010172 mouse model Methods 0.000 abstract 1
- 239000007800 oxidant agent Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4726—Lectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10494198P | 1998-10-20 | 1998-10-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE402255T1 true ATE402255T1 (de) | 2008-08-15 |
Family
ID=22303258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99958659T ATE402255T1 (de) | 1998-10-20 | 1999-10-20 | Surfactant protein d zur vorbeugung und diagnose des lungenemphysems |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1995315B1 (de) |
| JP (1) | JP4807902B2 (de) |
| AT (1) | ATE402255T1 (de) |
| AU (1) | AU767774B2 (de) |
| BR (1) | BR9914645A (de) |
| CA (2) | CA2347248C (de) |
| DE (1) | DE69939179D1 (de) |
| DK (1) | DK1995315T3 (de) |
| ES (2) | ES2311307T3 (de) |
| IL (2) | IL142639A0 (de) |
| WO (1) | WO2000023569A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8933032B2 (en) | 1998-10-20 | 2015-01-13 | Children's Hospital Medical Center | Surfactant protein D for the treatment of disorders associated with lung injury |
| US20030221199A1 (en) * | 1998-10-20 | 2003-11-27 | Whitsett Jeffrey A. | Surfactant protein D for the prevention and diagnosis of pulmonary emphysema |
| US6838428B2 (en) * | 1998-10-20 | 2005-01-04 | Children's Hospital Medical Center | Surfactant protein D for the prevention and diagnosis of pulmonary emphysema |
| DK1440083T3 (da) | 2001-10-25 | 2013-03-25 | Medical Res Council | Molekyler |
| AU2003233428B2 (en) * | 2002-04-01 | 2008-07-31 | The University Of Texas Medical Branch | Treatment of lung disorder |
| SE0203591D0 (sv) * | 2002-12-04 | 2002-12-04 | Siemens Elema Ab | Förfarande för beredning av ett mediakament och en medicinsk anordning |
| CA2628472C (en) * | 2005-11-03 | 2015-01-27 | Children's Hospital Medical Center | Surfactant protein-d for prevention and treatment of lung infections and sepsis |
| US8883730B2 (en) * | 2006-09-29 | 2014-11-11 | Council Of Scientific And Industrial Research | Human lung surfactant protein, SP-D, modulates eosinophil activation and survival and enhances phagocytosis of apoptotic bosinophils |
| GB201402909D0 (en) | 2014-02-19 | 2014-04-02 | Univ Southampton | Treating infection |
| US10682396B2 (en) | 2015-06-09 | 2020-06-16 | B.G. Negev Technologies And Applications Ltd | Controlled release system for pulmonary delivery of surfactant protein D |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE201880T1 (de) * | 1989-07-11 | 2001-06-15 | Genentech Inc | Oberflächenaktive zusammensetzungen und verfahren |
| WO1994023582A1 (en) * | 1993-04-08 | 1994-10-27 | Genetic Therapy, Inc. | Adenoviral vectors including dna encoding lung surfactant protein |
-
1999
- 1999-10-20 CA CA2347248A patent/CA2347248C/en not_active Expired - Lifetime
- 1999-10-20 JP JP2000577281A patent/JP4807902B2/ja not_active Expired - Lifetime
- 1999-10-20 AT AT99958659T patent/ATE402255T1/de not_active IP Right Cessation
- 1999-10-20 CA CA2749553A patent/CA2749553C/en not_active Expired - Lifetime
- 1999-10-20 EP EP08012802.8A patent/EP1995315B1/de not_active Expired - Lifetime
- 1999-10-20 DK DK08012802.8T patent/DK1995315T3/da active
- 1999-10-20 DE DE69939179T patent/DE69939179D1/de not_active Expired - Lifetime
- 1999-10-20 AU AU15980/00A patent/AU767774B2/en not_active Expired
- 1999-10-20 WO PCT/US1999/024675 patent/WO2000023569A1/en not_active Ceased
- 1999-10-20 BR BR9914645-2A patent/BR9914645A/pt not_active Application Discontinuation
- 1999-10-20 ES ES99958659T patent/ES2311307T3/es not_active Expired - Lifetime
- 1999-10-20 IL IL14263999A patent/IL142639A0/xx unknown
- 1999-10-20 ES ES08012802.8T patent/ES2488692T3/es not_active Expired - Lifetime
- 1999-10-20 EP EP99958659A patent/EP1123383B1/de not_active Expired - Lifetime
-
2001
- 2001-04-17 IL IL142639A patent/IL142639A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2347248A1 (en) | 2000-04-27 |
| EP1995315A2 (de) | 2008-11-26 |
| WO2000023569A1 (en) | 2000-04-27 |
| JP4807902B2 (ja) | 2011-11-02 |
| CA2749553C (en) | 2015-09-15 |
| WO2000023569A8 (en) | 2003-11-06 |
| EP1123383A1 (de) | 2001-08-16 |
| IL142639A0 (en) | 2002-03-10 |
| WO2000023569A9 (en) | 2002-08-29 |
| DK1995315T3 (da) | 2014-07-28 |
| DE69939179D1 (de) | 2008-09-04 |
| EP1123383A4 (de) | 2002-07-17 |
| AU1598000A (en) | 2000-05-08 |
| BR9914645A (pt) | 2002-02-05 |
| EP1123383B1 (de) | 2008-07-23 |
| ES2488692T3 (es) | 2014-08-28 |
| EP1995315A3 (de) | 2010-06-23 |
| JP2002527102A (ja) | 2002-08-27 |
| ES2311307T3 (es) | 2009-02-01 |
| EP1995315B1 (de) | 2014-05-14 |
| IL142639A (en) | 2009-09-01 |
| CA2347248C (en) | 2011-09-20 |
| CA2749553A1 (en) | 2000-04-27 |
| AU767774B2 (en) | 2003-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE402190T1 (de) | Surfactant protein d zur vorbeugung und diagnose des lungenemphysems | |
| ATE402255T1 (de) | Surfactant protein d zur vorbeugung und diagnose des lungenemphysems | |
| WO2003038058A3 (en) | Surfactant protein d for the prevention and diagnosis of pulmonary emphysema | |
| Hatada et al. | Identification of a new imprinted gene, Rian, on mouse chromosome 12 by fluorescent differential display screening | |
| EP2470559A4 (de) | Gerinnungsfaktor-ix-zusammensetzungen sowie verfahren zu ihrer herstellung und verwendung | |
| CN109628454A (zh) | 斑马鱼糖原贮积症gys1和gys2基因突变体的构建方法 | |
| ATE319814T1 (de) | Luciferase, fluoreszenzproteine, für luciferase und fluoreszenzproteine kodierend nukleinsaüre und ihre verwendung in der diagnose, hoch- durchsatz screeningsverfahren | |
| JP2020515248A5 (de) | ||
| Tapia del Fierro et al. | SMCHD1 has separable roles in chromatin architecture and gene silencing that could be targeted in disease | |
| CN117567582A (zh) | 一种飞蝗Serpin5纯合突变体的制备方法及应用 | |
| AU762048B2 (en) | Allelic series of genomic modifications in cells | |
| Ge et al. | Differential susceptibility of transgenic mice expressing human surfactant protein B genetic variants to Pseudomonas aeruginosa induced pneumonia | |
| CN115992203B (zh) | 一种全基因组羟甲基化捕获测序的文库构建方法 | |
| Huang et al. | Epithelial‐specific knockout of the Rac1 gene leads to enamel defects | |
| CN109679962B (zh) | Fbn2基因及其应用 | |
| JP2008109867A5 (de) | ||
| Yang et al. | Different impact of two mutations of a novel compound heterozygous protein C deficiency with late onset thrombosis | |
| JP2009523022A (ja) | 組織プロテオームライブラリーの構築方法 | |
| De Grove et al. | Role Of Chemr23 Signaling In Diesel-Enhanced Allergic Airway Inflammation | |
| Iwaki et al. | Plgrkt-deficient female mice caused by a 1-bp deletion of exon4 can maintain colonies through sufficient lactation | |
| JP2003265166A5 (de) | ||
| Koenitzer et al. | Single Cell Transcriptomics Reveals Gene Expression Changes and Cell Populations Associated with Bleomycin-Induced Pulmonary Fibrosis | |
| DE502008002215D1 (de) | Protein zur chemoenzymatischen herstellung von l-threo-hydroxyaspartat | |
| Schoenborn | Human surfactant protein B expression in humanized transgenic mice | |
| Potts et al. | NQO1 as Essential Co-Factor for Innate Defense of Airway Epithelial Surfaces. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |